Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.

Choi JP, Foley M, Zhou Z, Wong WY, Gokoolparsadh N, Arthur JS, Li DY, Zheng X.

PLoS One. 2016 Aug 11;11(8):e0160833. doi: 10.1371/journal.pone.0160833. eCollection 2016.

2.

Corrigendum: Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, Arthur JS, Whitehead KJ, Awad IA, Li DY, Zheng X, Kahn ML.

Nature. 2016 Aug 25;536(7617):488. doi: 10.1038/nature18311. Epub 2016 May 25. No abstract available.

PMID:
27281211
3.

Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.

Zhou Z, Tang AT, Wong WY, Bamezai S, Goddard LM, Shenkar R, Zhou S, Yang J, Wright AC, Foley M, Arthur JS, Whitehead KJ, Awad IA, Li DY, Zheng X, Kahn ML.

Nature. 2016 Apr 7;532(7597):122-6. doi: 10.1038/nature17178. Epub 2016 Mar 30. Erratum in: Nature. 2016 May 25;536(7617):488.

4.

Deletion of Wntless in myeloid cells exacerbates liver fibrosis and the ductular reaction in chronic liver injury.

Irvine KM, Clouston AD, Gadd VL, Miller GC, Wong WY, Melino M, Maradana MR, MacDonald K, Lang RA, Sweet MJ, Blumenthal A, Powell EE.

Fibrogenesis Tissue Repair. 2015 Oct 15;8:19. doi: 10.1186/s13069-015-0036-7. eCollection 2015.

5.

Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats.

Wong WY, Ward LC, Fong CW, Yap WN, Brown L.

Eur J Nutr. 2017 Feb;56(1):133-150. doi: 10.1007/s00394-015-1064-1. Epub 2015 Oct 8.

PMID:
26446095
6.

Tocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed rats.

Wong WY, Poudyal H, Ward LC, Brown L.

Nutrients. 2012 Oct 22;4(10):1527-41. doi: 10.3390/nu4101527.

7.

Caffeine attenuates metabolic syndrome in diet-induced obese rats.

Panchal SK, Wong WY, Kauter K, Ward LC, Brown L.

Nutrition. 2012 Oct;28(10):1055-62. doi: 10.1016/j.nut.2012.02.013. Epub 2012 Jun 19.

PMID:
22721876
8.

Nutrapharmacology of tocotrienols for metabolic syndrome.

Weng-Yew W, Brown L.

Curr Pharm Des. 2011;17(21):2206-14. Review.

PMID:
21774781
9.

Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis.

Weng-Yew W, Selvaduray KR, Ming CH, Nesaretnam K.

Nutr Cancer. 2009;61(3):367-73. doi: 10.1080/01635580802582736.

PMID:
19373610

Supplemental Content

Loading ...
Support Center